SPN

The SPN gene encodes a protein known as Sialyltransferase 2, also referred to as ST2. This protein plays a crucial role in the sialylation of glycoproteins, which is essential for antigen-specific activation of T cells. It is involved in immune responses and has been linked to various signaling pathways, including those related to inflammation and cell adhesion. SPN mutations are associated with Wiskott-Aldrich Syndrome and Aleukemic Monocytic Leukemia Cutis. In terms of drug development, research is ongoing to explore the potential of SPN as a therapeutic target, with a focus on novel treatments for CNS conditions and treatment-resistant depression.